Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Operating Leases (2022 - 2026)

Updated

Amylyx Pharmaceuticals (AMLX) posted Operating Leases of $4.25 million for Q2 2026, down 19.8% from $5.3 million a year earlier and down 5.1% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, Amylyx Pharmaceuticals' Operating Leases came in at $4.7 million, up 914.7% from FY2024.

  • Annual Operating Leases shows a three-year compound annual growth rate of 3.5% (FY2022 to FY2025).
  • In prior years, Amylyx Pharmaceuticals' Operating Leases was $463,000 in FY2024 (-76.6%), $1.98 million in FY2023 (-53.3%) and $4.24 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q1 2025.
  • On a year-over-year basis, Operating Leases increased in three of the last seven quarters, with growth averaging 283.4%.
  • The strongest year-over-year quarter for Operating Leases in the past five years was Q4 2025, with growth of 914.7%; the weakest was Q3 2024, with a decline of 76.8%.
  • According to Business Quant data, Operating Leases for the three prior quarters was $4.48 million (Q1 2026), $4.7 million (Q4 2025) and $4.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.25 Mn
Mar 31, 2026 4.48 Mn
Dec 31, 2025 4.70 Mn
Sep 30, 2025 4.95 Mn
Jun 30, 2025 5.30 Mn
Mar 31, 2025 327,000.00
Dec 31, 2024 463,000.00
Sep 30, 2024 595,000.00
Jun 30, 2024 772,000.00
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.98 Mn
Sep 30, 2023 2.57 Mn
Jun 30, 2023 3.14 Mn
Mar 31, 2023 3.69 Mn
Dec 31, 2022 4.24 Mn
Sep 30, 2022 4.77 Mn
Jun 30, 2022 5.29 Mn
Mar 31, 2022 5.79 Mn
API Access

Amylyx Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=AMLX&period=max&api_key=YOUR_API_KEY